Sfoglia per RIVISTA
BLOOD
Collezione AOU San Luigi di Orbassano

  

Items : 20

Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse. in Blood / Blood. 2022 Oct 27;140(17):1907-1916. doi: 10.1182/blood.2022015560.

2022
ASL Torino 4
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Visco C; Dreyling M; Seymour JF; Stefani PM; Sciarra R; Chiappella A; Vitagliano O; Sartori R; Mannina D; Morello L; Nicoli P; Arcari A; Angelillo P; Williams ME; Marin-Niebla A; Cencini E; van Meerten T; Mocikova H; Duglosz-Danecka M; Auer RL; Pagani C; Bernard S; Infante G; Iadecola S; Crucitti L; Muzi C; Klener P; Giné E; Tucker D; et alii...

Mortality in ?-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization. in Blood / Blood. 2022 Mar 31;139(13):2080-2083. doi: 10.1182/blood.2021014862.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Cappellini MD; Piga A; Merella P; Tartaglione I; Miceli R; Casale M; Longo F; Pasanisi A; Casu G; Barella S; Origa R; Giuditta M; Graziadei G; Derchi G; Musallam KM; Pinto VM; Gianesin B; Forni GL;

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA. in Blood / Blood. 2022 Mar 10;139(10):1588-1592. doi: 10.1182/blood.2021014124.

2022
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Jiménez-Lorenzo MJ; Hernández-Rivas JÁ; Jaksic O; Busca A; Corradini P; Pagliuca A; Koehler P; Klimko N; Hoenigl M; Rá?il Z; Karlsson LK; Nunes-Rodrigues R; González-López TJ; Malak S; Loureiro-Amigo J; Glenthøj A; Córdoba-Mascuñano R; Weinbergerová B; Serrano L; Ribera-Santa Susana JM; Calbacho M; Bilgin YM; Sili U; van Doesum J; Labrador J; Falces-Romero I; Dragonetti G; Pagano L; Gomes-Silva M; et alii...

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. in Blood / Blood. 2022 Dec 29;140(26):2773-2787. doi: 10.1182/blood.2022017257.

2022
ASL Città di Torino
AOU Città della Salute di Torino
AOU Alessandria
AOU San Luigi di Orbassano

Cornely OA; Busca A; Koehler P; Hoenigl M; Corradini P; Pagliuca A; Passamonti F; Bonanni M; Sili U; Machado M; Rahimli L; Adži?-Vuki?evi? T; Labrador J; Verga L; Cattaneo C; Gräfe S; Hanáková M; Mladenovi? M; Liévin R; Nucci M; Prezioso L; Marchetti M; Rá?il Z; Demirkan F; Sacchi MV; Guidetti A; Fouquet G; Fernández N; Zambrotta G; et alii...

Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study. in Blood / Blood. 2020 Feb 20;135(8):534-541. doi: 10.1182/blood.2019002969.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Cavo M; Baccarani M; Rosti G; Tenti E; Laginestra MA; Pileri SA; Percesepe A; Mignone F; Vigneri P; Saglio G; Pane F; Errichiello S; Serra A; Stella S; Calistri E; Annunziata M; Bocchia M; Musolino C; Attolico I; Coluzzi S; Capodanno I; Girasoli M; Sancetta R; Salvucci M; Binotto G; Abruzzese E; D'Adda M; di Bona E; di Raimondo F; et alii...

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma. in Blood / Blood. 2016 Mar 3;127(9):1102-8. doi: 10.1182/blood-2015-08-662627. Epub 2016 Jan 4.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Liberati AM; Guglielmelli T; Ledda A; Zambello R; Ruggeri M; Maisnar V; Ciccone G; Conticello C; Pulini S; Bernardini A; Musolino C; Giuliani N; Gentili S; Pietrantuono G; De Paoli L; Falcone AP; Mina R; Patriarca F; Benevolo G; Offidani M; Bringhen S; Magarotto V; Montefusco V; Hajek R; Boccadoro M; Palumbo A;

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina. in Blood / Blood. 2015 Apr 30;125(18):2771-8. doi: 10.1182/blood-2014-09-601674. Epub 2015 Mar 12.

2015
AOU San Luigi di Orbassano

Wang J; Shen ZX; Saglio G; Jin J; Huang H; Hu Y; Du X; Li J; Meng F; Zhu H; Hu J; Wang J; Hou M; Hertle S; Menssen HD; Ortmann CE; Tribouley C; Yuan Y; Baccarani M; Huang X;

Decitabine in advanced chronic myelomonocytic leukemia in Blood

2013
AOU San Luigi di Orbassano

Santini V; Allione B; Levis A; Gioia D; Lunghi M; Poloni A; Cilloni D; Zini G; Sanna A; Rossi A; Terenzi A; Angelucci E; Finelli C; Onida F; Rossi G; Ferrero D; Saglio G; Masiera E;

EphA3 as a molecular target in multiple myeloma: Opportunity for a novel therapeutic approach with a specific monoclonal antibody in Blood

2013
AOU San Luigi di Orbassano

Caivano A; La Rocca F; Laurenzana I; Favole A; Airoldi I; Di Carlo E; Gaidano V; Bracco E; Villani O; Pietrantuono G; De Luca L; Morano A; Simeon V; Trino S; Berardi S; Basile A; Lackmann M; Vacca A; Musto P; Frassoni F; Cilloni D;

Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma in Blood

2012
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Palumbo A; Larocca A; Montefusco V; Rossi D; Carella AM; Mina R; Crippa C; Sciacca M; Galli M; Scalabrini DR; Marcatti M; Guglielmelli T; Giuliani N; La Verde G; Baldi I; Muccio VE; Boccadoro M; Corradini P;

Single-nucleotide polymorphisms of ABCB1 gene influence intracellular concentrations of Dasatinib in Blood

2012
AOU San Luigi di Orbassano

D'Avolio A; De Francia S; Ariaudo A; Simiele M; Cusato J; Fava C; Baietto L; Di Perri G; Saglio G;

Identification of EPHA3 as a new potential molecular target in multiple myeloma in Blood

2012
AOU San Luigi di Orbassano

Caivano A; La Rocca F; Favole A; Carturan S; Bracco E; Villani O; Pietrantuono G; Laurenzana I; De Luca L; Morano A; Simeon V; Trino S; Berardi S; Basile A; Vacca A; Musto P; Cilloni D;

Intensified chemo-immunotherapy including up-front autologous or allogeneic stem cell transplantation (SCT) for young patients with newly diagnosed peripheral T-cell lymphomas: Final results of a phase II multicenter prospective clinical trial in Blood

2012
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Parvis G; Salvi F; Bruno B; Baldini L; Patti C; Milone G; Ferreri AJM; Tarella C; Pileri SA; Dodero A;

Rituximab followed by involved fields radiotherapy (IF-RT) in stage I-II follicular lymphoma (FL): Long term results in Blood

2011
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ruella M; Filippi A; Russo ADI; Caracciolo D; Matteucci P; Magni M; Di Nicola M; Ricardi U; Montefusco V; Parvis G; Tarella C; Gianni AM; Devizzi L;

Male gender, quality of grafted cells, advanced age, rituximab and radiotherapy are the main factors that variously influence the occurrence of secondary malignancies following high-dose therapy and autograft: A GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) survey in 1,347 lymphoma patients in Blood

2009
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Rossi A; Benedetti F; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Corradini P; Zoli V; Mule A; Crocchiolo R; Bosa M; Barbui A; Di Nicola M; Caracciolo D; Sorio M; Gianni AM; Rambaldi A;

Chronic eosinophilic leukaemia (CEL) with FIP1L1-PDGFRalpha rearrangement (F/P): The response to imatinib (IM) is durable. a report of 33 patients with a follow -up of 30 to 92 months in Blood

2009
AOU San Luigi di Orbassano

Rondoni M; Ottaviani E; Cilloni D; Paolo Piccaluga P; Paolini S; Iacobucci I; Soverini S; Merante S; Messa F; Buccisano F; Tiribelli M; Pane F; Saglio G; Lauria F; Baccarani M; Martinelli G;

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: A phase 2 trial of the GIMEMA CML Working Party in Blood

2009
AOU San Luigi di Orbassano

Castagnetti F; Palandri F; Amabile M; Testoni N; Luatti S; Soverini S; Iacobucci I; Breccia M; Cambrin GR; Stagno F; Specchia G; Galieni P; Iuliano F; Pane F; Saglio G; Alimena G; Martinelli G; Baccarani M; Rosti G;

Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow in Blood

2003
AOU San Luigi di Orbassano

Gorin NC; Labopin M; Rocha V; Arcese W; Beksac M; Gluckman E; Ringden O; Ruutu T; Reiffers J; Bandini G; Falda M; Zikos P; Willemze R; Frassoni F; Abecasis M; Abráhamová J; Afanassiev BV; Aglietta M; Alabdulaaly A; Aleinikova O; Paolo Alessandrino E; Al Shemmari SH; Amadori D; Amadori S; Amos T; Andolina M; Andreesen R; Angelucci E; Anhuf J; et alii...

Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. in Blood / Blood. 2002 Sep 15;100(6):2246-8. doi: 10.1182/blood-2002-02-0584.

2002
AOU San Luigi di Orbassano

Bosio S; De Gobbi M; Roetto A; Zecchina G; Leonardo E; Rizzetto M; Lucetti C; Petrozzi L; Bonuccelli U; Camaschella C;

New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. in Blood / Blood. 2001 May 1;97(9):2555-60. doi: 10.1182/blood.v97.9.2555.

2001
AOU San Luigi di Orbassano

Roetto A; Totaro A; Piperno A; Piga A; Longo F; Garozzo G; Calì A; De Gobbi M; Gasparini P; Camaschella C;